Dashboard
Manage Tickers

ANAB


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

insiders-buying-yum-china-and-2-other-stocks
Insiders Buying Yum China And 2 Other Stocks
08/19/2024 13:04:12

truist-securities-maintains-hold-on-anaptysbio-raises-price-target-to-30
Truist Securities Maintains Hold on Anapty...
08/15/2024 12:37:59

Truist Securities analyst John Lee maintains AnaptysBio (NASDAQ:ANAB) with a Hold and raises the price target from $20 to $30.

hc-wainwright--co-reiterates-buy-on-anaptysbio-maintains-55-price-target
HC Wainwright & Co. Reiterates Buy on Anap...
08/14/2024 18:03:05

HC Wainwright & Co. analyst Emily Bodnar reiterates AnaptysBio (NASDAQ:ANAB) with a Buy and maintains $55 price target.

ubs-posts-upbeat-earnings-joins-victorias-secret-performance-food-group-kellanova-and-other-big-stocks-moving-higher-on-wednesday
UBS Posts Upbeat Earnings, Joins Victoria'...
08/14/2024 14:36:17

sp-500-rises-small-caps-outperform-as-july-consumer-price-index-fuels-fed-rate-cut-hopes-5-etfs-to-watch-wednesday
S&P 500 Rises, Small Caps Outperform As Ju...
08/14/2024 13:36:10

US inflation eases in July, keeping Fed rate cut hopes alive. Stocks rise, yields stable, dollar gains against yen. Tech and sm...

anaptysbio-announced-the-pricing-of-an-underwritten-offering-of-2750498-shares-of-its-common-stock-at-a-price-of-3650-per-share-representing-a-premium-of-around-10-to-anaptys-closing-price-on-aug-13-2024
AnaptysBio Announced The Pricing Of An Und...
08/14/2024 09:02:00

jp-morgan-maintains-overweight-on-anaptysbio-raises-price-target-to-75
JP Morgan Maintains Overweight on AnaptysB...
08/07/2024 17:06:49

JP Morgan analyst Anupam Rama maintains AnaptysBio (NASDAQ:ANAB) with a Overweight and raises the price target from $69 to $75.

4-analysts-assess-anaptysbio-what-you-need-to-know
4 Analysts Assess AnaptysBio: What You Nee...
08/06/2024 14:01:20

hc-wainwright--co-reiterates-buy-on-anaptysbio-maintains-55-price-target
HC Wainwright & Co. Reiterates Buy on Anap...
08/06/2024 10:35:27

HC Wainwright & Co. analyst Emily Bodnar reiterates AnaptysBio (NASDAQ:ANAB) with a Buy and maintains $55 price target.

anaptysbio-q2-2024-adj-eps-171-misses-089-estimate-sales-1100m-miss-2430m-estimate
AnaptysBio Q2 2024 Adj EPS $(1.71) Misses ...
08/05/2024 20:30:33

AnaptysBio (NASDAQ:ANAB) reported quarterly losses of $(1.71) per share which missed the analyst consensus estimate of $(0.89) ...

anaptysbio-investigational-arthritis-drug-might-have-better-efficacy-profile-than-eli-lillys-analyst
AnaptysBio Investigational Arthritis Drug ...
07/22/2024 18:53:08

HC Wainwright initiated coverage on AnaptysBio with a Buy rating and a $55 price target. AnaptysBio focuses on immunology thera...

hc-wainwright--co-initiates-coverage-on-anaptysbio-with-buy-rating-announces-price-target-of-55
HC Wainwright & Co. Initiates Coverage On ...
07/22/2024 10:46:39

HC Wainwright & Co. analyst Emily Bodnar initiates coverage on AnaptysBio (NASDAQ:ANAB) with a Buy rating and announces ...

jp-morgan-upgrades-anaptysbio-to-overweight-raises-price-target-to-69
JP Morgan Upgrades AnaptysBio to Overweigh...
07/19/2024 13:03:56

JP Morgan analyst Anupam Rama upgrades AnaptysBio (NASDAQ:ANAB) from Neutral to Overweight and raises the price target from ...

the-analyst-landscape-7-takes-on-anaptysbio
The Analyst Landscape: 7 Takes On AnaptysBio
05/10/2024 21:01:14

wedbush-reiterates-outperform-on-anaptysbio-maintains-34-price-target
Wedbush Reiterates Outperform on AnaptysBi...
05/10/2024 13:50:23

Wedbush analyst David Nierengarten reiterates AnaptysBio (NASDAQ:ANAB) with a Outperform and maintains $34 price target.

anaptysbio-q1-2024-adj-eps-164-misses-157-estimate-sales-7180m-beat-3967m-estimate
AnaptysBio Q1 2024 Adj EPS $(1.64) Misses ...
05/09/2024 21:13:12

AnaptysBio (NASDAQ:ANAB) reported quarterly losses of $(1.64) per share which missed the analyst consensus estimate of $(1.57) ...

anaptys-top-line-gemini-2-phase-3-clinical-trial-results-of-imsidolimab-in-generalized-pustular-psoriasis-patients-who-received-a-single-dose-of-750mg-iv-imsidolimab-53-achieved-a-gpp-physician-global-assessment-score-of-01-clear-or-almost-clear-skin-at-week-4
Anaptys Top-Line GEMINI-2 Phase 3 Clinical...
05/09/2024 21:06:19

All eight patients from GEMINI-1 who responded to a single intravenous (IV) imsidolimab dose and were subsequently re-randomize...

anaptys-to-receive-50m-upfront-cash-payment-from-sagard-healthcare-from-amended-agreement-in-exchange-for-additional-jemperli-royalties
Anaptys To Receive $50M Upfront Cash Payme...
05/09/2024 21:04:52

Anaptys to receive $50 million upfront cash payment from Sagard Healthcare Prior agreement amended to now expire once Sagard re...

leerink-partners-initiates-coverage-on-anaptysbio-with-outperform-rating-announces-price-target-of-47
Leerink Partners Initiates Coverage On Ana...
04/16/2024 16:10:47

Leerink Partners analyst David Risinger initiates coverage on AnaptysBio (NASDAQ:ANAB) with a Outperform rating and announce...

why-fastenal-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Fastenal Shares Are Trading Lower By A...
04/11/2024 17:33:07

Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter f...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION